Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorderActive, not recruitingPhase 22026-09-25NCT07277660

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

59 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atd002 21001HabikinoJapan1
Atd002 21004Tachikawa-shiJapan1
Atd002 21005SakaiJapan1
Atd002 21006YokohamaJapan1
Atd002 21007NagoyaJapan1
Atd002 21008SapporoJapan1
Atd002 41001PlevenBulgaria1
Atd002 41002SevlievoBulgaria1
Atd002 41004LovechBulgaria1
Atd002 41005SofiaBulgaria1
Atd002 41006SofiaBulgaria1
Atd002 41007PlovdivBulgaria1
Atd002 42001PragueCzechia1
Atd002 42002NáchodCzechia1
Atd002 42003PragueCzechia1
Atd002 42004PragueCzechia1
Atd002 42005PragueCzechia1
Atd002 43001Bad BentheimGermany1
Atd002 43004LeipzigGermany1
Atd002 43007MahlowGermany1
Atd002 44001DebrecenHungary1
Atd002 45001KatowicePoland1
Atd002 45002WarsawPoland1
Atd002 45003KrakowPoland1
Atd002 45004LodzPoland1